Privia Health Group Inc (PRVA) Stock Forecast & Price Target
Privia Health Group Inc · NASDAQ
$24.67-0.83 (-3.25%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering Privia Health Group Inc, 11 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $24.00 to $35.00, a moderate spread. The average target of $30.92 sits 25% above the current $24.67. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.26 next quarter toward $1.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Moderate Buy
Strong Buy00%
Buy1192%
Hold18%
Sell00%
Strong Sell00%
Based on 12 analysts giving stock ratings to Privia Health Group Inc.
As of Jul, 11 of 12 firms rate PRVA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
PRVA EPS & revenue forecast
EPS · NEXT QUARTER
$0.26
Range $0.17 – $0.33 · 11 analysts · -11% YoY
Next period, 11 analysts expect Privia Health Group Inc to earn $0.26 a share (range $0.17 – $0.33), versus $0.29 a year earlier. Full-year consensus is $0.95, growing to $1.10 the year after.
REVENUE · NEXT QUARTER
$612.1M
Range $581.5M – $661.7M · 11 analysts · +5% YoY
Revenue is expected to reach $612.1M (range $581.5M – $661.7M), +5.5% year-over-year. Full-year consensus is $2.4B, rising to $2.7B next year.
Top analysts covering Privia Health Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PRVA.
#1
David Scharf
JMP Securities · Rank #125
Buy
$30.00+21.6% to target
Overall win rate
46%
+ Follow
#2
Constantine Davides
JMP Securities · Rank #225
Buy
$31.00+25.7% to target
Overall win rate
34%
+ Follow
#3
Ryan MacDonald
Needham · Rank #386
Buy
$30.00+21.6% to target
Overall win rate
17%
+ Follow
#4
Andrew Mok
Barclays
Hold
$24.00-2.7% to target
Coverage
—
+ Follow
#5
Jailendra Singh
Truist Securities
Buy
No targeton PRVA
Coverage
—
+ Follow
PRVA stock forecast FAQ
What is PRVA's average 12-month price target?+
The 12 analysts with a live target average $30.92 for Privia Health Group Inc over the next 12 months, ranging from a $35.00 high to a $24.00 low.
Is PRVA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 12 analyst ratings, 11 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for PRVA?+
The Street-high target is $35.00 (Piper Sandler), and the Street-low is $24.00 (Barclays). The average of all 12 active targets is $30.92.
How many Wall Street analysts cover PRVA?+
12 analysts have an active rating on Privia Health Group Inc, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering PRVA?+
Among analysts who currently cover PRVA, David Scharf of JMP Securities has the strongest overall Quantellect track record (Rank #125). Their current call is Buy with a $30.00 target.
What is Privia Health Group Inc's projected EPS for next quarter?+
The consensus estimate is $0.26 per share (range $0.17 – $0.33) across 11 analysts. Full-year EPS is projected at $0.95, rising to $1.10 the following year.
How much revenue is Privia Health Group Inc expected to report next quarter?+
Consensus revenue is $612.1M (range $581.5M – $661.7M). Full-year revenue is projected at $2.4B, growing to $2.7B next year.
Have analysts been upgrading or downgrading PRVA lately?+
As of Jul, 11 of 12 firms rate PRVA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PRVA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
